Tibotec Pharmaceuticals Ltd.

Tibotec will be a global leader in the management of serious and life-threatening infections and associated conditions of high unmet medical need. It will achieve this by delivering innovative therapeutic and diagnostic solutions that provide significant benefits to patients worldwide. Tibotec recognizes its responsibility to collaborate in the international response to HIV/AIDS, a challenge which cannot be separated from the fight for gender equality and poverty reduction. The UN has recognized that investment in women is the most productive strategy for poverty reduction and development. For more information on Tibotec's multi-pronged approach to the HIV/AIDS pandemic, see the developing world and how Tibotec is delivering for women.